Elisabeth Engel en Santander Pioneros: Es la hora de apostar por la ciencia

Three protagonists of the medical research field in Spain debated in a new edition of the “Pioneros Santander” forum, organized virtually by El País Retina. Elisabeth Engel, group leader of Biomaterials for regenerative therapies at the Institute for Bioengineering of Catalonia (IBEC), Rocío Arroyo, CEO of Amadix and Eduardo Jorgensen, of Medicsen, also CEO, agreed to celebrate the greatest interest in their area of work, the intersection between science, technology and health, but at the same time they were cautious: there are no shortcuts in the most cutting-edge research, neither before Covid-19 nor after.

Read more…

A “faster and safer” therapy against tuberculosis

A team of international scientists led by the Institute for Bioengineering of Catalonia (IBEC) has developed a “faster, more effective and safer” therapy to eliminate infections of intracellular bacteria that cause diseases such as tuberculosis. Scientists participating in the study include Group Leader Giuseppe Battaglia and the researcher Loris Rizzello of IBEC.

Read more…

Magnet Alliance on the radio

Àngels Suarez, teacher at Gayarre school, explained the alliance between IBEC and the Gayarre School within the frame of the project “Magnet, alliances for educational success”. This initiative unites educational centres that have an unbalanced social composition with an institution of excellence for 4 years. This union will allow the educational centre to develop an innovative project that will become a reference project in its territory. During her intervention, she also shared with the audience a virtual experiment, easy to perform in our homes, to explain the density.

Read more…

Núria Montserrat in a feature article at the ERC’s covid-19 section: Stopping coronavirus at the gate

ERC grantee Nuria Montserrat and her team create tiny kidneys which are proving to be key in the search for coronavirus drugs. The researcher is working with other international researchers and found that a trial drug could block early stages of COVID19. The ERC has created a section which is updated with the latest news about the ERC-funded research in coronavirus.

Read more…

Núria Montserrat on TV talks about Covid-19

Nuria Montserrat, principal investigator of the “Pluripotency for organ regeneration” spoke today at Espejo Público about the research that her group is carrying out in collaboration with other international research groups to find a treatment to stop the virus from continuing infecting other cells, preventing the virus from replicating.

Read more…